After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Disposition
Reported value range
Not reported

Palleiko Benjamin L Chief Executive Officer

Transaction date Jun 11, 2026
Public filing date Jun 11, 2026
Filing lag Filed same day

KALV daily price context

Close on/before transaction
$27 Jun 10, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Stock Option (Right to Buy) on Common Stock
Quantity / price
52,600 shares
SEC ownership
Direct
Transaction code
D
Form
4
Filing identifier
0001366244-26-000012
Filing cohort

Transactions in this filing

Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 $0
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Current Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported
Kalvista Pharmaceuticals, Inc. KALV Disposition Jun 11, 2026 Not reported